Replies to post #314699 on Avid Bioservices Inc (CDMO)

[DrRocker]

The original comment was pure speculation based on zero facts, now you're asking why management has agreed to a bad deal?

I am opining that management's decision to go it alone in the clinical development of Bavituximab rather than partner as they stated was their preference on multiple occasions is the reason most long term shareholders stand little chance of recouping their losses much less achieving the astronomical value many of us thought would be the case.

[The Other Guy]

$12.50 now is equivalent to $1.78 pre RS. FACT

Steve King claimed partnerships were going to come to fruition in the coming year. FACT


Partnerships did not come to fruition. FACT

BOD went with go it alone strategy. FACT

Shareholders lost. FACT